Eli Lilly (LLY) is planning to bring Zepbound multi dose to the market within 30 days and obesity pill will be available to Medicare patients at launch.
Importance
Level 1
#ELI LILLY & CO#LLY.US#EQUITIES#EU SESSION#US SESSION#PHARMACEUTICALS#PHARMACEUTICALS (GROUP)#PHARMACEUTICALS, BIOTECHNOLOGY & LIFE SCIENCES#S&P 500 INDEX#ELI LILLY AND CO#LLY#US EQUITIES